Natriumchloride Dirinco (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchloride Dirinco, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular sodium and chloride levels and to expand intravascular volume in patients with hypovolemia, electrolyte imbalance, or dehydration.

GNH USA supplies Natriumchloride Dirinco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Customers benefit from reliable logistics and comprehensive technical support.

Natriumchloride Dirinco is an intravenous electrolyte solution used in fluid and electrolyte replacement therapy.

- Hypovolemia: restores circulating blood volume and improves tissue perfusion. - Electrolyte imbalance: normalizes serum sodium and chloride concentrations. - Dehydration: replenishes extracellular fluid losses and supports hemodynamic stability. - Surgical patients: supports intravascular volume during operative procedures. - Burn patients: replaces sodium and chloride lost through fluid shifts.

Natriumchloride Dirinco may be associated with the following adverse reactions observed in clinical use.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Hyperchloremia: increased serum chloride concentrations. - Local irritation: pain or erythema at the infusion site. - Phlebitis: inflammation of the vein. - Fluid overload: signs of edema or pulmonary congestion. - Hypertension: transient rise in blood pressure.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate intervention. - Cardiac arrhythmia: caused by rapid shifts in electrolyte balance. - Pulmonary edema: accumulation of fluid in the lungs. - Severe hypervolemia: dangerous excess of intravascular fluid. - Metabolic acidosis: rare disturbance of acid‑base balance.

When using Natriumchloride Dirinco, consider the following precautions to ensure safe administration.

- Assess fluid status: evaluate volume needs before initiating therapy. - Monitor serum electrolytes: check sodium and chloride levels regularly. - Adjust infusion rate in cardiac failure: avoid rapid volume expansion. - Use caution in renal impairment: reduced excretion may lead to accumulation. - Avoid rapid infusion in neonates: slower rates reduce risk of circulatory overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Natriumchloride Dirinco can interact with other agents; the interactions are grouped by clinical significance.

Major Interactions (Avoid): - Hypertonic saline solutions: combined use can cause severe hypernatremia. - Potassium chloride IV solutions: simultaneous infusion may precipitate electrolyte imbalance. - Certain diuretics (e.g., loop diuretics): can exacerbate sodium loss.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance risk of hyperkalemia when combined with other electrolytes. - Corticosteroids: can affect fluid retention and electrolyte balance. - Other intravenous fluids: monitor total volume to prevent overload.